However, Dr Ivy Cheng, the University of Manchester research associate, who had reviewed evidence from over 30 randomised controlled trials, says there is unfortunately only limited evidence to ...
Cala Health has finalised the initial closing of an oversubscribed growth round of $50m to support the expansion of patient access to its neurostimulation therapy. Nexus NeuroTech Ventures and ...
Cala Health has finalised the initial closing of an oversubscribed growth round of $50m to support the expansion of patient access to its neurostimulation therapy. Nexus NeuroTech Ventures and Vertex ...
Salvia BioElectronics has raised 26 million euros ($30 million) in new financing to fund development of a neurostimulation therapy for chronic migraine. Neurostimulation has been proven as an ...